Start for free
Start for free
SL

Samsung Life Science Fund

Description

Samsung Life Science Fund is an investment firm.

Investor Profile

Samsung Life Science Fund has made 3 investments, with 2 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (33%)
  • Series C (33%)
  • Series Unknown (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Genetics
  • Life Science
  • Artificial Intelligence (Ai)
  • Medical
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Samsung Life Science Fund frequently co-invest with?

Gaingels
Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
Modi Ventures
Modi Ventures
North America, Texas, United States, Houston
Co-Investments: 1
BC
Bluwave Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
8VC
8VC
North America, California, United States, San Francisco
Co-Investments: 1
Ben Franklin Technology Partners
Ben Franklin Technology Partners
North America, Pennsylvania, United States, University Park
Co-Investments: 1
DCVC Bio
DCVC Bio
North America, California, United States, San Francisco
Co-Investments: 1
Longevity Vision Fund
Longevity Vision Fund
North America, New York, United States, New York
Co-Investments: 1
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
Flagship Pioneering
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

What are some of recent deals done by Samsung Life Science Fund?

Generate Biomedicines

Somerville, Massachusetts, United States

Generate Biomedicines is a biotech company that combines biology, machine learning, and biological engineering to create biomedicines.

Artificial Intelligence (AI)BiotechnologyHealth CareMedicalProduct Research
Series UnknownDec 18, 2024
Latus Bio

Philadelphia, Pennsylvania, United States

Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients.

BiopharmaBiotechnologyGenetics
Series AMay 2, 2024
Amount Raised: $54,000,000
Senda Biosciences

Cambridge, Massachusetts, United States

Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.

BiotechnologyHealth CareLife Science
Series CAug 16, 2022
Amount Raised: $123,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator